FDA advisers urge closer scrutiny of pelvic mesh

WASHINGTON — Advisers to the Food and Drug Administration say trouble-prone medical products widely used to surgically repair women's pelvic problems need stringent testing for safety and effectiveness.

1. Don't miss these Health stories
   1. 
      Facebook is now fueling organ donations

      Becky Melton’s “friend” request to Jerry Wilde, a complete stranger in dire need of a new kidney, came with a photo and a gift. The texted photo: a picture of Melton, 28, holding a hand-drawn sign showing two kidneys and a message -- “We’re a match!

   2. Why you should smile at strangers
   3. Grill, drive, play: Doc's tips for Memorial Day safety
   4. Cheating guys more likely to die of a heart attack
   5. German doctors apologize for Holocaust horrors

It's another case of a problem that wasn't flagged until patients got hurt.

The advisory panel on Thursday urged the FDA to reclassify plastic surgical mesh used to repair pelvic collapse. The consensus recommendation means that, if the FDA agrees, manufacturers would be required to prove the safety and effectiveness of the products.

Consumer groups want a recall, but medical device makers say mesh offers advantages, and the rate of serious complications is low. The FDA said in July it had underestimated the risks, which include pain, bleeding and infection.

The agency often follows the recommendations of its advisers.